{
  "main_header": {
    "sid": 555664,
    "name": "Bal Pharma",
    "stock_name": "Bal Pharma",
    "full_name": "Bal Pharma Ltd",
    "name_url": "stocks-analysis/bal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "105.70",
    "chg": 2.83,
    "chgp": "2.75%",
    "dir": 1,
    "prev_price": "102.87",
    "mcapval": "168.28 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524824,
    "symbol": "BALPHARMA",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE083D01012",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:29 AM",
    "bse_nse_vol": "30.6 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bal-pharma-555664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bal Pharma's Surge Highlights Positive Momentum in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-stock-hits-upper-circuit-limit-with-intraday-high-of-rs-108-34-1695849",
        "imagepath": "",
        "date": "2025-04-03 11:00:13",
        "description": "Bal Pharma Ltd, a microcap player in the Pharmaceuticals & Drugs industry, has experienced significant activity today, hitting its upper circuit limit. The stock reached an intraday high of Rs 108.34, reflecting a remarkable increase of 19.99% from the previous close. This surge is part of a broader trend, as Bal Pharma has shown consistent gains over the past three days, accumulating a total return of 29.13% during this period.\n\nThe stock traded within a wide range, with a low of Rs 91.84, and a total traded volume of approximately 3.64 lakh shares, resulting in a turnover of Rs 3.90 crore. Notably, Bal Pharma's performance today outpaced its sector, which gained 2.56%, and the stock outperformed the Sensex, which saw a slight decline of 0.19%.\n\nDespite a decrease in delivery volume, which fell by 62.02% compared to the five-day average, the stock remains liquid enough for trading activities. Overall, Bal ..."
      },
      {
        "title": "Bal Pharma Ltd Experiences Surge with 20% Daily Gain Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-surges-20-today-reaching-intraday-high-of-rs-109-04-amid-strong-buying-activity-1694741",
        "imagepath": "",
        "date": "2025-04-03 10:05:09",
        "description": "Bal Pharma Ltd is currently witnessing significant buying activity, with the stock surging by 20.00% today, in stark contrast to the Sensex, which has declined by 0.45%. Over the past week, Bal Pharma has recorded a remarkable 30.98% increase, while the Sensex has fallen by 1.72%. This trend continues with a 34.62% rise over the past month, compared to the Sensex's modest gain of 4.36%.\n\nThe stock has been on a positive trajectory for the last three days, accumulating a total return of 31.37%. Today, it reached an intraday high of Rs 109.04, reflecting high volatility with an intraday fluctuation of 8.34%. Notably, Bal Pharma's performance has outpaced its sector, which has gained 3.35%.\n\nDespite a challenging three-month period where the stock fell by 14.14%, its long-term performance remains strong, with a 244.52% increase over the past five years. The stock is currently trading above its 5-day, 20-day, a..."
      },
      {
        "title": "Bal Pharma Faces Significant Volatility Amidst Declining Stock Performance and Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-hits-new-52-week-low-as-stock-declines-14-23-in-three-days-1173061",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/BalPharma_priceRelatedfactors_562580.png",
        "date": "2025-03-03 10:36:01",
        "description": "Bal Pharma, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low of Rs. 82, reflecting significant volatility and a 14.23% decline over three days. The stock has underperformed its sector and is trading below key moving averages, indicating a challenging market position."
      },
      {
        "title": "Bal Pharma Faces Significant Trading Volatility Amidst Ongoing Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-hits-new-52-week-low-amid-significant-stock-decline-and-volatility-1141508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/BalPharma_priceRelatedfactors_549229.png",
        "date": "2025-02-28 11:05:19",
        "description": "Bal Pharma, a microcap in the Pharmaceuticals & Drugs sector, has faced notable volatility, reaching a new 52-week low and experiencing a significant decline over the past two days. The stock's performance has been marked by high intraday fluctuations and underperformance compared to its sector and the broader market over the past year."
      },
      {
        "title": "Bal Pharma Hits New Low Amid Broader Sector Challenges and Declining Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-hits-new-52-week-low-at-rs-88-5-amid-ongoing-decline-1045144",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/BalPharma_priceRelatedfactors_459315.png",
        "date": "2025-02-18 13:45:19",
        "description": "Bal Pharma has reached a new 52-week low, continuing a downward trend with a notable decline over the past three days. The company's one-year performance shows a significant drop, contrasting with positive returns in the broader market. The stock is trading below key moving averages, indicating ongoing challenges."
      },
      {
        "title": "Bal Pharma Reports Financial Results Amidst Notable Evaluation Shift in December 2024",
        "link": "https://www.marketsmojo.com/news/result-analysis/bal-pharma-reports-financial-decline-with-score-dropping-to-9-in-december-2024-1010940",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/BalPharma_quaterlyResult_446146.png",
        "date": "2025-02-14 11:47:38",
        "description": "Bal Pharma has announced its financial results for the quarter ending December 2024, revealing a notable shift in performance. The company is facing challenges in the competitive pharmaceuticals sector, prompting stakeholders to closely monitor future developments that may affect its overall evaluation."
      }
    ],
    "total": 31,
    "sid": "555664",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/bal-pharma-555664"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "04-Apr-2025",
      "details": "We are submitting the certificate in compliance with Regulation 74(5) of SEBI(DP) Regulations for the quarter ended 31.03.2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Scheme of Arrangement",
      "datetime": "28-Mar-2025",
      "details": "Honble NCLT Bangalore bench has approved the scheme of arrangement between Golden Drugs Pvt Ltd ( Transferer Company) a wholly owned subsidiary of the Company with Bal Pharma Ltd ( Transferee Company ) vide its order dated 26.03.2025.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2025",
      "details": "Trading window for dealing with the securities of the Company on designated persons and their immediate relatives will be closed from 1st April 2025 and upto 48 hours of announcing the audited financial results of the Company for the financial year ended 31.03.2025. The date of the Board meeting for announcing the audited financial results will be intimated to the exchanges shortly.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bal Pharma Ltd has declared <strong>12%</strong> dividend, ex-date: 17 Sep 24",
          "dt": "2024-09-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bal Pharma's Surge Highlights Positive Momentum in Pharmaceuticals Sector

2025-04-03 11:00:13

Bal Pharma Ltd, a microcap player in the Pharmaceuticals & Drugs industry, has experienced significant activity today, hitting its upper circuit limit. The stock reached an intraday high of Rs 108.34, reflecting a remarkable increase of 19.99% from the previous close. This surge is part of a broader trend, as Bal Pharma has shown consistent gains over the past three days, accumulating a total return of 29.13% during this period. The stock traded within a wide range, with a low of Rs 91.84, and a total traded volume of approximately 3.64 lakh shares, resulting in a turnover of Rs 3.90 crore. Notably, Bal Pharma's performance today outpaced its sector, which gained 2.56%, and the stock outperformed the Sensex, which saw a slight decline of 0.19%. Despite a decrease in delivery volume, which fell by 62.02% compared to the five-day average, the stock remains liquid enough for trading activities. Overall, Bal ...

Read More

Bal Pharma Ltd Experiences Surge with 20% Daily Gain Amid Broader Market Decline

2025-04-03 10:05:09

Bal Pharma Ltd is currently witnessing significant buying activity, with the stock surging by 20.00% today, in stark contrast to the Sensex, which has declined by 0.45%. Over the past week, Bal Pharma has recorded a remarkable 30.98% increase, while the Sensex has fallen by 1.72%. This trend continues with a 34.62% rise over the past month, compared to the Sensex's modest gain of 4.36%. The stock has been on a positive trajectory for the last three days, accumulating a total return of 31.37%. Today, it reached an intraday high of Rs 109.04, reflecting high volatility with an intraday fluctuation of 8.34%. Notably, Bal Pharma's performance has outpaced its sector, which has gained 3.35%. Despite a challenging three-month period where the stock fell by 14.14%, its long-term performance remains strong, with a 244.52% increase over the past five years. The stock is currently trading above its 5-day, 20-day, a...

Read More

Bal Pharma Faces Significant Volatility Amidst Declining Stock Performance and Market Challenges

2025-03-03 10:36:01

Bal Pharma, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low of Rs. 82, reflecting significant volatility and a 14.23% decline over three days. The stock has underperformed its sector and is trading below key moving averages, indicating a challenging market position.

Read More

Bal Pharma Faces Significant Trading Volatility Amidst Ongoing Market Challenges

2025-02-28 11:05:19

Bal Pharma, a microcap in the Pharmaceuticals & Drugs sector, has faced notable volatility, reaching a new 52-week low and experiencing a significant decline over the past two days. The stock's performance has been marked by high intraday fluctuations and underperformance compared to its sector and the broader market over the past year.

Read More

Bal Pharma Hits New Low Amid Broader Sector Challenges and Declining Performance

2025-02-18 13:45:19

Bal Pharma has reached a new 52-week low, continuing a downward trend with a notable decline over the past three days. The company's one-year performance shows a significant drop, contrasting with positive returns in the broader market. The stock is trading below key moving averages, indicating ongoing challenges.

Read More

Bal Pharma Reports Financial Results Amidst Notable Evaluation Shift in December 2024

2025-02-14 11:47:38

Bal Pharma has announced its financial results for the quarter ending December 2024, revealing a notable shift in performance. The company is facing challenges in the competitive pharmaceuticals sector, prompting stakeholders to closely monitor future developments that may affect its overall evaluation.

Read More

View All News